CASEY WARD: Open Payments
NPI 1043751845 · PORT JEFFERSON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$347 in 12 payments from 7 companies in 2025. Trend: 2023 $406 · 2024 $747 · 2025 $347
Food & beverage: $300Education: $47
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 4 | $119 |
| HARMONY BIOSCIENCES LLC | 2 | $92 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $35 |
| PFIZER INC. | 2 | $35 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $26 |
| SCILEX PHARMACEUTICALS INC. | 1 | $23 |
| ARGENX US, INC. | 1 | $18 |
Products named: INGREZZA, WAKIX, HYQVIA, JOURNAVX, ZTLido, NURTEC ODT, VYVGART, PANZYGA.
Industry payments across NY — which companies pay providers there.
